V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250006723 | 250004758 | 1.52 | 65 | Disease modification (D) | 2014-08-07 | 2014-08-08 | Trial Unspecified | 02 | N | 250030080 | RUXOLITINIB |
| 250006727 | 250004760 | 1.52 | 56.7 | Disease modification (D) | 2014-01-30 | 2014-01-31 | INTERFERON | 2 | N | 250030087 | RUXOLITINIB |
| 250006728 | 250004760 | 1.72 | 81.2 | Curative (C) | 2013-12-26 | 2014-01-16 | Imatinib 400mg | N | N | 250030087 | CHOP R |
| 250006729 | 250004760 | 0 | null | Curative (C) | 2013-12-26 | 2014-05-04 | RUXOLITINIB | 2 | N | 250030087 | RUXOLITINIB |
| 250006730 | 250004761 | 0 | 0 | Palliative (P) | 2014-09-13 | 2014-09-15 | PEG INTERFERON | N | N | 250030090 | RUXOLITINIB |
| 250006731 | 250004762 | 0 | 94.5 | Curative (C) | 2014-09-03 | 2014-09-04 | PEG INTERFERON | 2 | N | 250030099 | BUSULPHAN |
| 250006732 | 250004763 | 1.58 | 107.1 | null | 2014-09-17 | 2014-09-19 | Bortezomib + Cyclophos + Dex | N | N | 250030100 | PEG INTERFERON |
| 250006733 | 250004763 | null | null | Palliative (P) | 2013-02-21 | 2013-03-14 | Trial Unspecified | N | N | 250030100 | RUXOLITINIB |
| 250006734 | 250004763 | null | 106 | Curative (C) | 2017-01-13 | 2017-01-22 | Nilotinib | null | null | 250030100 | BENDAMUSTINE + RITUXIMAB |
| 250006735 | 250004763 | 1.7 | 64.9 | Palliative (P) | 2018-06-18 | 2018-06-18 | RUXOLITINIB | 2 | null | 250030100 | ANAGRELIDE |
| 250006737 | 250004765 | 1.58 | 0 | Palliative (P) | 2013-03-11 | 2013-03-11 | RUXOLITINIB | N | N | 250030120 | BUSULPHAN |
| 250006739 | 250004766 | 1.62 | 72 | Palliative (P) | 2017-01-15 | 2017-01-31 | FLAG + Idarubicin | N | N | 250030140 | TRIAL |
| 250006740 | 250004766 | null | null | Palliative (P) | null | 2015-04-29 | BUSULFAN | N | null | 250030140 | ANAGRELIDE |
| 250006741 | 250004767 | 1.67 | 105.5 | Disease modification (D) | 2015-05-01 | 2015-05-01 | RUXOLITINIB | 02 | null | 250030147 | RITUXIMAB |
| 250006742 | 250009594 | null | 84.8 | Adjuvant (A) | 2018-11-04 | 2018-11-04 | RUXOLITINIB | 2 | null | 250030148 | PACLITAXEL |
| 250006743 | 250004768 | 1.78 | 0 | Curative (C) | 2015-05-11 | 2015-05-15 | Azacitidine | N | N | 250030151 | LENALIDOMIDE |
| 250006744 | 250004769 | 1.72 | null | Palliative (P) | 2013-12-20 | 2014-01-01 | RUXOLITINIB | N | N | 250030160 | RUXOLITINIB |
| 250006745 | 250004770 | 1.79 | 86 | Palliative (P) | 2016-01-11 | 2016-01-14 | Trial Unspecified | 02 | N | 250030162 | RUXOLITINIB |
| 250006746 | 250004771 | 1.77 | 74 | Curative (C) | 2013-11-16 | 2013-11-16 | RUXOLITINIB | N | null | 250030167 | METHOTREXATE |
| 250006747 | 250004772 | 0 | 140.9 | Palliative (P) | 2013-12-15 | 2014-02-01 | Rituximab | N | N | 250030169 | RUXOLITINIB |
| 250006748 | 250009595 | 1.83 | 82.9 | Palliative (P) | 2014-11-22 | 2014-11-25 | Rituximab | N | N | 250030171 | RUXOLITINIB |
| 250006749 | 250009595 | 1.71 | 69 | Palliative (P) | 2014-02-01 | 2014-02-02 | Rituximab | 02 | N | 250030171 | RUXOLITINIB |
| 250006750 | 250009595 | null | null | Adjuvant (A) | 2016-03-13 | 2016-03-15 | Busulfan Oral | 02 | null | 250030171 | IMATINIB |
| 250006751 | 250004773 | 1.7 | 85 | null | null | 2017-02-24 | RUXOLITINIB | null | N | 250030177 | RUXOLITINIB |
| 250006752 | 250004774 | null | 93.2 | Palliative (P) | 2015-11-21 | 2015-11-29 | RUXOLITINIB | 02 | N | 250030178 | RUXOLITINIB |
| 250006753 | 250004775 | 1.84 | 104.6 | Palliative (P) | 2017-12-07 | 2017-12-07 | RUXOLITINIB | N | N | 250030182 | RUXOLITINIB |
| 250006754 | 250004776 | 1.69 | null | Curative (C) | 2014-12-14 | 2014-12-14 | RUXOLITINIB | 02 | N | 250030183 | RUXOLITINIB |
| 250006755 | 250004776 | null | 81.7 | Palliative (P) | 2014-07-16 | 2014-07-16 | BUSULFAN | 02 | N | 250030183 | BUSULPHAN |
| 250006756 | 250004776 | 1.75 | 106 | Curative (C) | 2015-11-22 | 2015-11-24 | RUXOLITINIB | 2 | N | 250030183 | BUSULPHAN |
| 250006757 | 250004776 | 1.58 | 0 | Curative (C) | null | 2014-03-14 | RUXOLITINIB | N | N | 250030183 | RUXOLITINIB |
| 250006758 | 250004776 | 1.74 | 0 | Palliative (P) | 2013-09-18 | 2013-09-19 | AML 18 TRIAL | N | N | 250030183 | RUXOLITINIB |
| 250006759 | 250004777 | null | null | null | 2013-06-28 | 2013-07-07 | RUXOLITINIB | N | N | 250030197 | RUXOLITINIB |
| 250006761 | 250009597 | 1.8 | 0 | Disease modification (D) | 2018-04-04 | 2018-04-29 | Azacitidine | N | N | 250030202 | INTERFERON |
| 250006762 | 250004779 | 0 | 95.3 | Disease modification (D) | 2015-11-26 | 2015-12-10 | Chlorambucil | 2 | N | 250030204 | RITUXIMAB |
| 250006763 | 250004780 | null | 77.3 | Disease modification (D) | 2017-09-02 | 2017-09-10 | BUSULFAN | null | N | 250030205 | RUXOLITINIB |
| 250006764 | 250004781 | 0 | 73.8 | Curative (C) | 2016-09-13 | 2016-09-13 | RUXOLITINIB | 2 | N | 250030208 | RUXOLITINIB |
| 250006765 | 250004782 | 1.69 | 92.5 | Palliative (P) | 2014-11-19 | 2014-12-03 | RUXOLITINIB | N | N | 250030209 | RITUXIMAB |
| 250006766 | 250004783 | 0 | 100 | Disease modification (D) | 2016-05-20 | 2016-05-20 | IMATINIB | N | N | 250030211 | RUXOLITINIB |
| 250006767 | 250004784 | 1.56 | 73.8 | Disease modification (D) | 2017-11-12 | 2017-11-12 | RUXOLITINIB | N | N | 250030212 | RITUXIMAB |
| 250006768 | 250004785 | null | 76.3 | Palliative (P) | 2016-12-28 | 2016-12-30 | RUXOLITINIB | 02 | N | 250030213 | BUSULPHAN |
| 250006769 | 250004785 | 1.83 | 82.4 | null | 2015-12-09 | 2015-12-16 | Rituximab | N | N | 250030213 | PEG INTERFERON |
| 250006770 | 250011565 | 1.78 | 82 | Disease modification (D) | 2016-08-20 | 2016-08-31 | Dasatinib | N | N | 250030219 | RUXOLITINIB |
| 250006771 | 250004786 | 1.56 | null | Palliative (P) | 2015-09-09 | 2015-09-15 | CYTARABINE + DAUNORUBICIN | 02 | Y | 250030222 | BUSULPHAN |
| 250006772 | 250004787 | 1.64 | 0 | Palliative (P) | null | 2013-10-17 | RUXOLITINIB | N | N | 250030226 | AZACITIDINE |
| 250006773 | 250009599 | 1.63 | null | Palliative (P) | 2016-10-12 | 2016-10-15 | Rituximab | 02 | N | 250030228 | PEG INTERFERON |
| 250006774 | 250004788 | 1.61 | 66.5 | Disease modification (D) | 2013-12-12 | 2013-12-19 | Rituximab | N | N | 250030231 | ANAGRELIDE |
| 250006775 | 250004789 | 1.7 | null | Palliative (P) | 2018-07-11 | 2018-07-23 | RUXOLITINIB | N | N | 250030232 | ANAGRELIDE |
| 250006776 | 250009600 | null | 59 | null | 2015-07-08 | 2015-07-08 | PEG INTERFERON | null | N | 250030234 | RITUXIMAB |
| 250006777 | 250004790 | 1.82 | 94.9 | Adjuvant (A) | 2017-08-11 | 2017-08-14 | RUXOLITINIB | N | N | 250030238 | RUXOLITINIB |
| 250006778 | 250004791 | 0 | 60 | Disease modification (D) | 2013-10-01 | 2013-10-08 | RUXOLITINIB | N | N | 250030242 | RUXOLITINIB |